“Novel Inhibitor of Brain Indoleamine 2,3 Dioxygenase, Docking and Experimental Studies”. 2017. International Current Pharmaceutical Journal 6 (6): 34-39. https://doi.org/10.3329/icpj.v6i6.34180.